Figure 3.
Forest plots of hazard ratios for progression-free survival in patients with gastric or gastroesophageal junction cancer between PD-1/PD-L1 inhibitor group and chemotherapy group.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.